Injection Articles
Genzyme's Synvisc-One awarded EU CE mark
24 December 2007
FDA accepts MGI's Aquavan NDA
24 December 2007
FDA clears Thyrogen for use in ablation
24 December 2007
India's NPPA revises 164 product prices
24 December 2007
Pharmion's Vidaza achieves survival benefit in MDS
17 December 2007
Rivaroxaban cuts VTE risk in RECORD-1 trial
17 December 2007
Telvancin non-inferior in HAP/VAP studies
17 December 2007
Ipsen filed BSA for Dysport with FDA
10 December 2007
$200M cash injection for polio vacc campaign
3 December 2007
Strong early data for ImmuFact IMP321 in breast cancer
3 December 2007
MMI's 1st-half loss up 12% on admin costs
3 December 2007
Daval cleared to start Ph IIb Aimspro study
3 December 2007
Ardana's BPH drug effective with just two annual doses
26 November 2007
UK firm develops new method of light-activating MAbs
26 November 2007
Altana benefits show through at Nycomed
26 November 2007
Primlintide/leptin combo produces 12.7% weight loss, says Amylin
26 November 2007
Benda to enter India's $204M oncology market
26 November 2007
Pfizer makes $164M bid for Coley Pharma to expand in vaccines
26 November 2007
Bayer temporarily stops Trasylol marketing
21 November 2007
LEEM defends therapy support programs
19 November 2007
USA's HealthTrust signs 3-year renewal for Bayer's Magnevist
19 November 2007
Betaseron linked to fewer injection site reactions
12 November 2007
US FDA clears Merck KGaA's easypod
12 November 2007
Samaritan gets Amphocil MAA in Cyprus
12 November 2007
Breast cancer market set to reach $2.9B in 2013, but still no cure
12 November 2007
Elan sees 3rd-qtr loss narrow, sales rise 43%
12 November 2007
New Trasylol warnings after BART study deaths
5 November 2007
Strong safety data on Theratechnologies' tesamorelin
5 November 2007
Less IV procedure pain with Anesiva's Zingo
5 November 2007
Hana's Alocrest displays efficacy in solid tumor trial
5 November 2007
Supplemental indication for Chugai's Sigmart
5 November 2007
Vaprisol raises sodium levels in hyponatremia
5 November 2007
Strong safety data for Cytori's Celution System
29 October 2007
Japan's MHLW clears Novo Nordisk's Levemir
29 October 2007
Amylin's 3rd-qtr net loss narrows to $39.8M
29 October 2007
Eli lilly sees 3rd qtr net income climb 6% as sales jump 19% to $4.6B, raises full-year guidance
29 October 2007
AFSSAPS gives OK to Ph III Genasense trial
22 October 2007
FDA clears Ortho-McNeil's Doribax
22 October 2007
Abraxis gains two FDA OKs for fludarabine
22 October 2007
Anesiva and Sagent in deal to co-promote Zingo to US hospitals
22 October 2007
Merck KGaA
15 October 2007
Sirtris' SRT501 shows potential in optic neuritis model
15 October 2007
Bracco and Health Trust in contrast media deal
15 October 2007
Biojector withdrawn from US FDA review
15 October 2007
MGI Pharma submits Aquavan NDA in USA
8 October 2007
Alcon's Retaane gets FDA approvable letter
1 October 2007
Lilly files Alimta with EMEA for NSCLC
1 October 2007
Merck & Co's Cancidas comparable to AmBisome in IFI
1 October 2007
Teva's edratide disappoints in Ph II SLE trial
24 September 2007
Dabigatran as effective in VTE as enoxaparin
24 September 2007
CRDAC recommends FDA OK for Trasylol
17 September 2007
Hyperion secures $40M in financing
10 September 2007
Ipsen's Somatuline Depot cleared in USA
10 September 2007
Biovitrum's 2nd-qtr 2007 income soars 33%
10 September 2007
Biferonex MAA submitted to EMEA
3 September 2007
Genta enrolls first patients in Ph III Genasense trial
3 September 2007
Bayer did not withhold Trasylol safety data
3 September 2007
Fast-track for Adventrx' ANX-510
3 September 2007
Anesiva's Zingo cleared by FDA
3 September 2007
Novartis' Reclast approved by US FDA
20 August 2007
Auxilium to resume Ph III US trials of Xiafelx
20 August 2007
Recruitment opens in Ph II Velcade combo MM trial
20 August 2007
Abraxis gains expedited appro of generic cefotetan
20 August 2007
Teva's 2nd-qtr 2007 net sales rise 10% to $2.39B
20 August 2007
Cytogen's 2nd-qtr net loss widens to $10.4M
20 August 2007
Hana initiates Ph II Marqibo AML study
13 August 2007
NICE wet AMD drug rethink after 13,000 complaints
13 August 2007
US FDA approves Abraxis' sNDA for oxycotin
13 August 2007
Vectura's QDose shows efficacy in study
13 August 2007
Chinese firm Simcere 2nd-qtr revenues and income leap
13 August 2007
Alkermes sees fiscal 1st-qtr net income of $8.7M
13 August 2007
ImClone's 2nd-qtr profit drops 14% to $319M
13 August 2007
Elan's 2nd-qtr 2007 loss deepens 56%
6 August 2007
BioAlliance Pharma in 40M-euro fund raising
6 August 2007
Lilly's 2nd-qtr 20% sales hike beats estimates
30 July 2007
Premier extends deal with Bayer for contrast media
30 July 2007
ProStrakan submits Sancuso MAA
23 July 2007
FDA accepts Collegium's opioid product IND
23 July 2007
Tercica and Genentech sign R&D deal
16 July 2007
Stock Commentary - New York week to July 9, 2007
16 July 2007
Boeh Ing's dabigatran as effective as enoxaparin
16 July 2007
Genzyme's hylastan falls short in OA trial
16 July 2007
EC approves Merck KGaA's Pergoveris
9 July 2007
GenVec's HIV vacc enters Ph I trial
2 July 2007
IDM Pharma to raise $25M in direct offering
2 July 2007
FAES to launch second ibandronate brand
25 June 2007
UK's NICE "fails common sense test"
25 June 2007
Norditropin gets FDA OK for Noonan syndrome
18 June 2007
Japan's Chuikyo adds 13 NCEs to NHI list
18 June 2007
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
